http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0521923-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e84439f61c706d09b2d3e54f0ffc68e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H23-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 |
| filingDate | 1991-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_353a193f7c3edeb008d1c6dbe162764d |
| publicationDate | 1993-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0521923-A1 |
| titleOfInvention | METHOD FOR PRODUCING NUCLEOSIDES AND THEIR ANALOGS. |
| abstract | A new process for the production of a nucleoside such as cytarabine, or an analog, comprising the step of reacting a 2,2'-O-cyclonucleoside or an analog with an amine. The process is preferably carried out in the presence of an aqueous solvent. The invention also relates to a novel process for the production of 2,2'-O-cyclonucleoside precursor compounds and their pharmaceutically acceptable salts, comprising the reaction of a 2,3'-O-dialkylstannylene nucleoside compound with an amine in the presence of a sulfonyl compound. Cytarabine is a known antineoplastic and antiviral agent. |
| priorityDate | 1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.